We are live on ! Find out more
AKTX

Akari Therapeutics
AKTX

6 hedge funds and large institutions have $308K invested in Akari Therapeutics in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.17% less ownership

Funds ownership: 0.31% → 0.15% (-0.17%)

68% less funds holding

Funds holding: 19 → 6 (-13)

76% less capital invested

Capital invested by funds: $1.29M → $308K (-$978K)

86% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 14

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
-13
Holders Change %
-68.42%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$69.5K
2
Morgan Stanley
Morgan Stanley
New York
+$9

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$273K
2
WAM
Warberg Asset Management
Illinois
-$88.7K
3
PAI
Palo Alto Investors
California
-$42.2K
4
HighTower Advisors
HighTower Advisors
Illinois
-$22.9K
5
Jane Street
Jane Street
New York
-$20.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$200K -$273K -29,177 -43%
CAM
2
Cresset Asset Management
Illinois
$106K -$9 -1 -0%
IA
3
IFP Advisors
Florida
$1.81K +$69.5K +7,431 New
SS
4
SBI Securities
Japan
$26 – – –
TC
5
Truvestments Capital
Florida
$5 – – –
Morgan Stanley
6
Morgan Stanley
New York
$5 +$9 +1 New
WAM
7
Warberg Asset Management
Illinois
– -$88.7K -7,709 Closed
PAI
8
Palo Alto Investors
California
– -$42.2K -3,651 Closed
HighTower Advisors
9
HighTower Advisors
Illinois
– -$22.9K -1,981 Closed
Jane Street
10
Jane Street
New York
– -$20.7K -1,791 Closed
SP
11
SmartHarvest Portfolios
Washington
– -$20K -1,731 Closed
CAMG
12
CWA Asset Management Group
Florida
– -$15.9K -1,375 Closed
XT
13
XTX Topco
Cayman Islands
– -$14.2K -1,225 Closed
UBS Group
14
UBS Group
Switzerland
– -$9.5K -821 Closed
Cerity Partners
15
Cerity Partners
New York
– -$6.83K -591 Closed
SG
16
StoneX Group
New York
– -$6.15K -532 Closed
IAA
17
Independent Advisor Alliance
North Carolina
– -$4.93K -427 Closed
NA
18
NewEdge Advisors
Louisiana
– -$1.97K -170 Closed
ACM
19
Accent Capital Management
Ohio
– -$1.45K -125 Closed
Bank of America
20
Bank of America
North Carolina
– -$118 -10 Closed
CPG
21
Cornerstone Planning Group
New Jersey
– -$1 – –

AKTX Hedge Fund Activity: Q1 2026 in Review

6 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q1 2026, worth a combined $308K — down 76% from $1.29M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AKTX and 2 opened new positions — a net loss of 12 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $69.5K. The largest seller was Armistice Capital, cutting an estimated $273K.

  • 6 institutional investors held Akari Therapeutics (AKTX) as of Q1 2026, down from 19 in Q4 2025.
  • Funds reported $308K of Akari Therapeutics stock for Q1 2026, down 76% quarter-over-quarter.
  • 2 funds opened new Akari Therapeutics positions in Q1 2026 and 14 closed out, a net change of -12 holders.
  • The largest Akari Therapeutics buyer in Q1 2026 was IFP Advisors, an estimated $69.5K added.
  • The largest Akari Therapeutics seller in Q1 2026 was Armistice Capital, an estimated $273K sold.

Based on aggregated 13F filings for Q1 2026.